JP2024523166A5 - - Google Patents

Info

Publication number
JP2024523166A5
JP2024523166A5 JP2023574290A JP2023574290A JP2024523166A5 JP 2024523166 A5 JP2024523166 A5 JP 2024523166A5 JP 2023574290 A JP2023574290 A JP 2023574290A JP 2023574290 A JP2023574290 A JP 2023574290A JP 2024523166 A5 JP2024523166 A5 JP 2024523166A5
Authority
JP
Japan
Prior art keywords
nucleic acid
antigen
expression vector
seq
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023574290A
Other languages
English (en)
Japanese (ja)
Other versions
JP7901102B2 (ja
JP2024523166A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033625 external-priority patent/WO2022266219A1/en
Publication of JP2024523166A publication Critical patent/JP2024523166A/ja
Publication of JP2024523166A5 publication Critical patent/JP2024523166A5/ja
Application granted granted Critical
Publication of JP7901102B2 publication Critical patent/JP7901102B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023574290A 2021-06-15 2022-06-15 クローディン18.2及びcd3に結合するヘテロ二量体抗体 Active JP7901102B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163210787P 2021-06-15 2021-06-15
US63/210,787 2021-06-15
PCT/US2022/033625 WO2022266219A1 (en) 2021-06-15 2022-06-15 Heterodimeric antibodies that bind claudin18.2 and cd3

Publications (3)

Publication Number Publication Date
JP2024523166A JP2024523166A (ja) 2024-06-28
JP2024523166A5 true JP2024523166A5 (cg-RX-API-DMAC7.html) 2025-06-23
JP7901102B2 JP7901102B2 (ja) 2026-08-05

Family

ID=82608587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574290A Active JP7901102B2 (ja) 2021-06-15 2022-06-15 クローディン18.2及びcd3に結合するヘテロ二量体抗体

Country Status (4)

Country Link
US (1) US20240247062A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355784A1 (cg-RX-API-DMAC7.html)
JP (1) JP7901102B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022266219A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025122927A1 (en) * 2023-12-06 2025-06-12 Integral Molecular, Inc. Antibodies directed to claudin 18.2, including bispecific formats thereof
WO2026055669A2 (en) * 2024-09-09 2026-03-12 Xencor, Inc. Anti-tl1a x anti-il23 antibodies

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459007A (en) 1891-09-08 Porte
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20060134105A1 (en) 2004-10-21 2006-06-22 Xencor, Inc. IgG immunoglobulin variants with optimized effector function
JP2007512846A (ja) 2003-12-04 2007-05-24 ゼンコー・インコーポレイテッド 増加した宿主ストリング含有量を有する変異体タンパク質の生成方法およびその組成物
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
CN103429620B (zh) 2010-11-05 2018-03-06 酵活有限公司 在Fc结构域中具有突变的稳定异源二聚的抗体设计
IL282953B2 (en) 2012-11-13 2026-02-01 Tron Translationale Onkologie An Der Johannes Gutenberg Univ Mainz Gemeinnutzige Gmbh Agents for the treatment of claudin-expressing cancers
WO2014075697A1 (en) * 2012-11-13 2014-05-22 Biontech Ag Agents for treatment of claudin expressing cancer diseases
KR102391731B1 (ko) 2013-01-14 2022-04-27 젠코어 인코포레이티드 신규한 이형이량체 단백질
EP3587448B1 (en) 2013-03-15 2021-05-19 Xencor, Inc. Heterodimeric proteins
PL3122781T3 (pl) 2014-03-28 2020-06-15 Xencor, Inc. Dwuswoiste przeciwciała, które wiążą się z CD38 i CD3
RU2019102008A (ru) * 2016-06-28 2020-07-28 Ксенкор, Инк. Гетеродимерные антитела, которые связывают рецептор соматостатина 2-го типа
WO2018054484A1 (en) * 2016-09-23 2018-03-29 Biontech Ag Bispecific trivalent antibodies binding to claudin 6 or claudin18.2 and cd3 for treatment of claudin expressing cancer diseases
CN112469477A (zh) * 2018-04-04 2021-03-09 Xencor股份有限公司 与成纤维细胞活化蛋白结合的异源二聚体抗体
EP3808376A4 (en) * 2018-06-17 2021-09-01 L&L Biopharma Co., Ltd. CLDN18.2 ANTIBODY, BISPECIFIC ANTIBODY, ADC AND CAR, AND APPLICATIONS THEREOF
BR112021002032A2 (pt) * 2018-08-03 2021-07-20 Amgen Research (Munich) Gmbh construtos de anticorpos para cldn18.2 e cd3
CN110862454B (zh) * 2018-08-27 2022-12-30 南京圣和药业股份有限公司 一种抗Claudin18_2抗体及其应用
CA3147122A1 (en) * 2019-07-12 2021-01-21 Futuregen Biopharmaceutical (Beijing) Co., Ltd. Cldn18.2 antibody and use thereof
CN114364701A (zh) * 2019-07-17 2022-04-15 加利福尼亚大学董事会 密封蛋白18抗体和治疗癌症的方法
AU2020378502A1 (en) * 2019-11-05 2022-06-16 LaNova Medicines Limited Antibody-drug conjugates targeting claudin 18.2
JP7641967B2 (ja) * 2019-12-06 2025-03-07 ソティオ バイオテック エイ.エス. ヒト化cldn18.2抗体

Similar Documents

Publication Publication Date Title
JP2025508827A5 (cg-RX-API-DMAC7.html)
JP2021019642A5 (cg-RX-API-DMAC7.html)
JP2021151253A5 (cg-RX-API-DMAC7.html)
JP2022503959A5 (cg-RX-API-DMAC7.html)
AR120511A2 (es) Producción de proteínas heteromultiméricas
JP2005516613A5 (cg-RX-API-DMAC7.html)
JP2025066711A5 (cg-RX-API-DMAC7.html)
JP2014506790A5 (cg-RX-API-DMAC7.html)
JP2019201661A5 (cg-RX-API-DMAC7.html)
JP2005120106A5 (cg-RX-API-DMAC7.html)
JP2016104045A5 (cg-RX-API-DMAC7.html)
DE602005022830D1 (de) Weniger immunogene bindungsmoleküle
JP2018520654A5 (cg-RX-API-DMAC7.html)
RU2013140685A (ru) ВАРИАНТЫ Fc, СПОСОБЫ ИХ ПОЛУЧЕНИЯ
CL2008002349A1 (es) Molecula de anticuerpo que se une a cd37 humano; molecula de adn que la codifica; vector de expresion y celula huesped; metodo para producir dicho anticuerpo; composicion farmaceutica que la comprende; método in vitro para suprimir células b que expresan cd37 en una población de células.
JP2025090679A5 (cg-RX-API-DMAC7.html)
EA201001436A1 (ru) Клетка, сбраживающая пентозный сахар
RU2011154363A (ru) Комбинации клад rrgb пневмококков
JP2004528803A5 (cg-RX-API-DMAC7.html)
JP2023171909A5 (cg-RX-API-DMAC7.html)
JP2024516962A5 (cg-RX-API-DMAC7.html)
EA201400192A1 (ru) Клетка, ферментирующая пентозы
JPWO2023282161A5 (cg-RX-API-DMAC7.html)
PE20230090A1 (es) Anticuerpos contra el factor de las celulas madre y metodos de uso de ellos
MX2022009988A (es) Neoantigenos expresados en mieloma multiple y sus usos.